Monday, May 11, 2026

"hyderabad-company"

Hyderabad-based Aurobindo Pharma recalls over 4,000 bottles of pain relieving drug

US-based unit of the drug major is recalling Acetaminophen Tablets (325 mg) in the US due to cGMP (Current Good Manufacturing Practices) deviations
Hyderabad-based Granules India net profit up 17 per cent in Q4 FY25

Revenue from operations increased to Rs 1,197 crore for the fourth quarter as compared with Rs 1,176 crore in the year-ago period
Hyderabad-based MedPlus sees 12 per cent rise in net profit in Q4 of FY25

Company’s board approved appointment of Subrahmanyam Sharma Tatapudi as Chief Technology Officer, effective 27 May 2025